PER 0.00% 10.5¢ percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-235

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,415 Posts.
    lightbulb Created with Sketch. 1439
    Thanks for your input
    Here’s the thing
    If the readout re DMD trial is Stella good
    FDA could give Per the green light as soon as end 24 ..
    PER has stated that they will take the Tox first to the FDA
    Then take the readout to the FDA soon after..
    Because of the urgency for DMD sufferers there is no time to waste
    FDA has set a precedence ..
    We wait

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.